Active efflux of dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly-targeted agents

The importance of the blood-brain barrier in preventing effective pharmacotherapy of glioblastoma has been controversial. The controversy stems from the fact that vascular endothelial cell tight junctions are disrupted in the tumor, allowing some systemic drug delivery. P-glycoprotein (Pgp) and brea...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Agarwal, Sagar, Mittapalli, Rajendar K., Zellmer, David M., Gallardo, Jose L., Donelson, Randy, Seiler, Charlie, Decker, Stacy A., SantaCruz, Karen S., Pokorny, Jenny L., Sarkaria, Jann N., Elmquist, William F., Ohlfest, John R.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3469747/
https://ncbi.nlm.nih.gov/pubmed/22891038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0552
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires